Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Learn how Volatility Dividend Aristocrats Etf behaves across cycles and what it means for risk budgeting and position sizing in volatile markets.
20,128 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Oil prices fall, stock futures rise as reports of a U.S.-backed cease-fire plan with Iran surface, setting up a cauti...
Paysign's 2025 earnings paint a picture of a niche fintech player balancing steady card-services revenue with new par...
A $130,000 insider sale at CorVel raises questions for investors. This guide breaks down what the move could mean, ho...
Oil prices pressed higher on March 26, 2026, nearing the mid-$100s per barrel. The move highlights how current price ...
This in-depth analysis explores what could drive ASML stock in 2026, with practical scenarios, risk factors, and clea...
Robinhood's stock dropped about 6% after the company unveiled a $1.5 billion buyback. Yet investors remain skeptical ...
A West Coast airline pilot gains approval to slash his own 401(k) contributions after his employer offers a 17% match...
Bitcoin continues its climb for the month, pressing into a critical resistance zone. Traders await a confirmed breako...
Retirement planning goes beyond a bank balance. This guide shows how to retire with confidence by aligning money, hea...
AI stocks soared for years, then faced a rigorous test as valuations and demand shifted. This article breaks down wha...
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...